SwanBio Therapeutics Appoints Alison Lawton to Board of Directors

PHILADELPHIA--(BUSINESS WIRE)--SwanBio Therapeutics (SwanBio), a gene therapy company advancing AAV-based therapies for the treatment of devastating, genetically defined neurological conditions, today announced the appointment of Alison Lawton to the company’s Board of Directors...
Login to comment.